Showing results (11-20 of 35) with videos related to
Sort By:
Pageof 4
Case Reports in Oncology|November 25, 2015
Five Simultaneous Primary Tumors in a Single Patient: A Case Report and Review of the LiteratureCasey W Williamson, Anthony Paravati, Majid Ghassemi, et al.Journal of Translational Medicine|May 18, 2021
Gene alterations as predictors of radiation-induced toxicity in head and neck squamous cell carcinomaWhitney Sumner, Xenia Ray, Leisa Sutton, et al.World Neurosurgery|March 20, 2018
Cystic Formation After Stereotactic Radiosurgery of Brain MetastasisAli A Alattar, Kate Carroll, Brian R Hirshman, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|August 4, 2023
Increased risk for ex-vacuo ventriculomegaly with leukoencephalopathy (EVL) in whole brain radiation therapy and repeat radiosurgery treated brain metastasis patientsAli A Alattar, Sanjay Dhawan, Jiri Bartek, et al.International Journal of Particle Therapy|July 21, 2021
Beam-Specific Spot Guidance and Optimization for PBS Proton Treatment of Bilateral Head and Neck CancersKarla Leach, Shikui Tang, Jared Sturgeon, et al.The Laryngoscope|July 18, 2023
Early Improved Functional Outcomes in Head and Neck Cancer Patients with Primary Tumor DetectionSandhya Kalavacherla, Benjamin Bernard, Sangwoo S Kim, et al.The Oncologist|May 28, 2017
Exceptional Response to Nivolumab and Stereotactic Body Radiation Therapy (SBRT) in Neuroendocrine Cervical Carcinoma with High Tumor Mutational Burden: Management Considerations from the Center For Personalized Cancer Therapy at UC San Diego Moores Cancer CenterAndrew Sharabi, Sangwoo Shawn Kim, Shumei Kato, et al.Head & Neck|February 7, 2019
Implementation of submandibular gland transfer: A multi-institutional study of feasibility and time to treatmentJohn Pang, Harry H Ching, Ryan H Sobel, et al.Journal of Translational Medicine|August 12, 2022
Germline genetic biomarkers to stratify patients for personalized radiation treatmentIda Deichaite, Austin Hopper, Lena Krockenberger, et al.Lung Cancer (Amsterdam, Netherlands)|February 13, 2025
Brain metastases and mortality in patients with ALK + metastatic non-small cell lung cancer treated with second-generation ALK tyrosine kinase inhibitors as first-line targeted therapies: An observational cohort studyDipesh Uprety, Devin Abrahami, Zachary A Marcum, et al.Pageof 4